D-0939-2023 Class II Terminated

Recalled by Glenmark Therapeutics, Inc. — Mahwah, NJ

Recall Details

Product Type
Drugs
Report Date
July 26, 2023
Initiation Date
May 1, 2023
Termination Date
September 17, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19,968 bottles

Product Description

Famotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark Therapeutics Inc., USA, Mahwah, NJ 07430, Made in India, NDC 72657-113-20.

Reason for Recall

Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.

Distribution Pattern

Nationwide in the USA

Code Information

FA2022001B, Exp 03/2025